Ironwood/Forest Hoping To Change The Conversation About Constipation
This article was originally published in The Pink Sheet Daily
Executive Summary
The partners began a DTC campaign to promote their constipation drug and ease the conversation between physicians and patients about the often embarrassing condition.
You may also be interested in...
Ironwood Could Use Linzess As Model For GERD Market
The biotech has moved into mid-stage studies with a heartburn drug that will face OTC competition, much like Linzess has battled with in the area of constipation.
Actavis Flexes Its Commercial Muscles Ahead Of Allergan Integration
Before adding Allergan into the mix – and taking on its name – Actavis wants to show investors that it has a solid foundation as a growth pharma with strong brands in GI, CNS and women’s health.
Synthetic Biologics Thinks Statins May Get At Root Of IBS-Constipation
Biotech set to develop patented special-release statin formulation for a new approach to constipation-predominant irritable bowel syndrome – methane gas. The same research also underpins development of Salix’ Xifaxan for diarrhea-predominant IBS.